Literature DB >> 18261017

Bone mass in young adults with Down syndrome.

M Guijarro1, C Valero, B Paule, J Gonzalez-Macias, J A Riancho.   

Abstract

BACKGROUND: Down syndrome (DS) is a frequent cause of intellectual disability. With the increasing life expectancy of these patients, concerns have been raised about the risk of osteoporosis. In fact, several investigators have reported a reduced bone mass in DS. However, the results may be confounded by comorbid diseases, and differences in lifestyle habits and body size. Therefore, we planned to determine anthropometric and lifestyle factors influencing bone mineral density (BMD) in young adults with DS.
METHODS: Thirty-nine patients with DS (mean age 26 years) and 78 controls were studied. Areal BMD was measured by dual x-ray densitometry (DXA); volumetric BMD at the lumbar spine and femoral neck was estimated with published formulae.
RESULTS: DS patients had lower areal BMD than controls at all regions (spine, hip and total body). Height and projected bone area were also lower. There were no differences between both groups regarding estimated volumetric BMD at the femoral neck. However, spine volumetric BMD was also lower in DS than controls. In multivariate analysis, DS, male sex, little physical activity and low sunlight exposure were associated with lower spine volumetric BMD; on the other hand, fat mass and sunlight exposure were associated with femoral neck volumetric BMD.
CONCLUSION: This study shows that patients with DS had a reduced areal BMD, but it is in part a consequence of the reduced body size, particularly at the femoral neck. Physical activity and sunlight exposure are associated to volumetric BMD and should be stimulated in order to maintain an adequate bone mass in these patients.

Entities:  

Mesh:

Year:  2008        PMID: 18261017     DOI: 10.1111/j.1365-2788.2007.00992.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  25 in total

1.  Cortical and trabecular bone at the radius and tibia in male and female adolescents with Down syndrome: a peripheral quantitative computed tomography (pQCT) study.

Authors:  A González-Agüero; G Vicente-Rodríguez; A Gómez-Cabello; J A Casajús
Journal:  Osteoporos Int       Date:  2012-06-09       Impact factor: 4.507

2.  Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice.

Authors:  Joshua D Blazek; Anna Gaddy; Rachel Meyer; Randall J Roper; Jiliang Li
Journal:  Bone       Date:  2010-09-24       Impact factor: 4.398

3.  Effect of whole body vibration training on bone mineral density and bone quality in adolescents with Down syndrome: a randomized controlled trial.

Authors:  A Matute-Llorente; A González-Agüero; A Gómez-Cabello; H Olmedillas; G Vicente-Rodríguez; J A Casajús
Journal:  Osteoporos Int       Date:  2015-05-21       Impact factor: 4.507

4.  Effect of whole-body vibration training on bone mass in adolescents with and without Down syndrome: a randomized controlled trial.

Authors:  A Matute-Llorente; A González-Agüero; A Gómez-Cabello; J Tous-Fajardo; G Vicente-Rodríguez; J A Casajús
Journal:  Osteoporos Int       Date:  2015-07-23       Impact factor: 4.507

5.  Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.

Authors:  Megan Stringer; Irushi Abeysekera; Jared Thomas; Jonathan LaCombe; Kailey Stancombe; Robert J Stewart; Karl J Dria; Joseph M Wallace; Charles R Goodlett; Randall J Roper
Journal:  Physiol Behav       Date:  2017-05-03

Review 6.  Aneuploidy and skeletal health.

Authors:  Archana Kamalakar; John R Harris; Kent D McKelvey; Larry J Suva
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

7.  Diverging results of areal and volumetric bone mineral density in Down syndrome.

Authors:  M García-Hoyos; M T García-Unzueta; D de Luis; C Valero; J A Riancho
Journal:  Osteoporos Int       Date:  2016-11-12       Impact factor: 4.507

8.  Low bone turnover and low bone density in a cohort of adults with Down syndrome.

Authors:  K D McKelvey; T W Fowler; N S Akel; J A Kelsay; D Gaddy; G R Wenger; L J Suva
Journal:  Osteoporos Int       Date:  2012-08-18       Impact factor: 4.507

9.  Bone mass and density in preadolescent boys with and without Down syndrome.

Authors:  J Wu
Journal:  Osteoporos Int       Date:  2013-05-17       Impact factor: 4.507

Review 10.  Endocrine and musculoskeletal abnormalities in patients with Down syndrome.

Authors:  Yousra Hawli; Mona Nasrallah; Ghada El-Hajj Fuleihan
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.